Fabrice Egros - Net Worth and Insider Trading

Fabrice Egros Net Worth

The estimated net worth of Fabrice Egros is at least $336,960 dollars as of 2024-04-29. Fabrice Egros is the Director of Syndax Pharmaceuticals Inc and owns about 16,000 shares of Syndax Pharmaceuticals Inc (SNDX) stock worth over $336,960. Details can be seen in Fabrice Egros's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Fabrice Egros has not made any transactions after 2021-11-18 and currently still holds the listed stock(s).

Transaction Summary of Fabrice Egros

To

Fabrice Egros Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Fabrice Egros owns 1 companies in total, including Syndax Pharmaceuticals Inc (SNDX) .

Click here to see the complete history of Fabrice Egros’s form 4 insider trades.

Insider Ownership Summary of Fabrice Egros

Ticker Comapny Transaction Date Type of Owner
SNDX Syndax Pharmaceuticals Inc 2021-11-18 director

Fabrice Egros Latest Holdings Summary

Fabrice Egros currently owns a total of 1 stock. Fabrice Egros owns 16,000 shares of Syndax Pharmaceuticals Inc (SNDX) as of November 18, 2021, with a value of $336,960.

Latest Holdings of Fabrice Egros

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SNDX Syndax Pharmaceuticals Inc 2021-11-18 16,000 21.06 336,960

Holding Weightings of Fabrice Egros


Fabrice Egros Form 4 Trading Tracker

According to the SEC Form 4 filings, Fabrice Egros has made a total of 4 transactions in Syndax Pharmaceuticals Inc (SNDX) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Syndax Pharmaceuticals Inc is the sale of 14,030 shares on November 18, 2021, which brought Fabrice Egros around $252,961.

Insider Trading History of Fabrice Egros

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Fabrice Egros Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Fabrice Egros Ownership Network

Ownership Network List of Fabrice Egros

No Data

Ownership Network Relation of Fabrice Egros


Fabrice Egros Owned Company Details

What does Syndax Pharmaceuticals Inc do?

Who are the key executives at Syndax Pharmaceuticals Inc?

Fabrice Egros is the director of Syndax Pharmaceuticals Inc. Other key executives at Syndax Pharmaceuticals Inc include director & Chief Executive Officer Briggs Morrison , Chief Financial Officer Keith A. Goldan , and President & Head of R&D Neil Gallagher .

Syndax Pharmaceuticals Inc (SNDX) Insider Trades Summary

Over the past 18 months, Fabrice Egros made no insider transaction in Syndax Pharmaceuticals Inc (SNDX). Other recent insider transactions involving Syndax Pharmaceuticals Inc (SNDX) include a net sale of 369,983 shares made by Briggs Morrison , a net sale of 50,069 shares made by Peter Ordentlich , and a net sale of 83,000 shares made by William Meury .

In summary, during the past 3 months, insiders sold 0 shares of Syndax Pharmaceuticals Inc (SNDX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 548,588 shares of Syndax Pharmaceuticals Inc (SNDX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 548,588 shares.

Syndax Pharmaceuticals Inc (SNDX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Syndax Pharmaceuticals Inc Insider Transactions

No Available Data

Fabrice Egros Mailing Address

Above is the net worth, insider trading, and ownership report for Fabrice Egros. You might contact Fabrice Egros via mailing address: C/o Syndax Pharmaceuticals, Inc., Totten Pond Road, Suite 140, Waltham Ma 02451.

Discussions on Fabrice Egros

No discussions yet.